Irena Marjanović

Assistant Research Professor
Laboratory for Molecular Biomedicine

Institute of molecular genetics and genetic engineering (IMGGE),
University of Belgrade

Vojvode Stepe 444a, 11042 Belgrade 152, Serbia
Mobile: +381 65 3976445
Phone: +381 11 3976 445
Fax:     +381 11 397 58 08


2018 - PhD in Molecular Biology, Faculty of Biology (FB), University of Belgrade (UB)
(Thesis: Identification of molecular genetic markers of acute myeloid leukemia pathogenesis)
2011 - PhD studies. Module - Molecular Biology of Eukaryotes, Faculty of Biology (FB), University of Belgrade
2010 - B. Sc. in Molecular Biology and Physiology, FB, University of Belgrade


2013 - Research Assistant in Laboratory for Molecular Biomedicine (LMB), IMGGE
2012 - 2013 - Research Trainee, LMB, IMGGE
2011 - 2012 - Volunteer, LMB, IMGGE


Acute and chronic leukemia in adults and children. Genetic basis and the abberation in the process of differentiation, proliferation and apoptosis. Molecular markers significant for the diagnosis of disease, monitoring and treatment of hematologic malignancies.


  1. Todorovic Balint, Jelicic J, Mihaljevic B, Kostic J, Stanic B, Balint B, Pejanovic N, Lucic B, Tosic N, Marjanovic I, Stojiljkovic M, Karan-Djurasevic T, Perisic O, Rakocevic G, Popovic M, Raicevic S, Bila J, Antic D, Andjelic B, Pavlovic S. “Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses.” Int J Mol Sci. 2016 May 6;17(5).
  2. Marjanovic I, Karan-Djurasevic T, Ugrin M, Virijevic M, Vidovic A, Tomin D, Suvajdzic Vukovic N, Pavlovic S, Tosic N. “Use of Wilms Tumor 1 Gene Expression as a Reliable Marker for Prognosis and Minimal Residual Disease Monitoring in Acute Myeloid Leukemia With Normal Karyotype Patients.“  Clin Lymphoma Myeloma Leuk. 2017 May;17(5):312-319.
  3. Marjanovic I, Kostic J, Stanic B, Pejanovic N, Lucic B, Karan-Djurasevic T, Janic D, Dokmanovic L, Jankovic S, Vukovic NS, Tomin D, Perisic O, Rakocevic G5, Popovic M, Pavlovic S, Tosic N. „Parallel targeted next generation sequencing of childhood and adult acute myeloid leukemia patients reveals uniform genomic profile of the disease.“ Tumor Biol. 2016 Oct;37(10):13391-13401.
  4. Virijevic M, Karan-Djurasevic T, Marjanovic I, Tosic N, Mitrovic M, Djunic I, Colovic N, Vidovic A, Suvajdzic-Vukovic N, Tomin D, Pavlovic S. “Somatic mutations of isocitrate dehydrogenases 1 and 2 are prognostic and follow-up markers in patients with acute myeloid leukaemia with normal karyotype.” Radiol Oncol. 2016 Sep 8;50(4):385-393.
  5. Bila J, Sretenovic A, Jelicic J, Tosic N, Glumac I, Fekete MD, Antic D, Balint MT, Markovic O, Milojevic Z, Radojkovic M, Trajkovic G, Puric M, Pavlovic S, Mihaljevic B. “Prognostic Significance of Cereblon Expression in Patients With Multiple Myeloma.” Clin Lymphoma Myeloma Leuk. 2016 Nov;16(11):610-615.
  6. Karan-Djurasevic T, Palibrk V, Zukic B, Spasovski V, Glumac I, Colovic M, Colovic N, Jurisic V, Scorilas A, Pavlovic S, Tosic N. “Expression of Bcl2L12 in chronic lymphocytic leukemia patients: association with clinical and molecular prognostic markers.” Med Oncol. 2013 Mar;30(1):405.
  7. Vucicevic K, Jakovljevic V, Colovic N, Tosic N, Kostic T, Glumac I, Pavlovic S, Karan-Djurasevic T, Colovic M. “Association of Bax Expression and Bcl2/Bax Ratio with Clinical and Molecular Prognostic Markers in Chronic Lymphocytic Leukemia.” J Med Biochem. 2016 Apr;35(2):150-157.

Please publish modules in offcanvas position.